Viewing Study NCT04949269


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2026-01-01 @ 7:12 AM
Study NCT ID: NCT04949269
Status: COMPLETED
Last Update Posted: 2022-03-11
First Post: 2021-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Drug Levels of Deucravacitinib From Tablets After Oral Administration in Healthy Participants
Sponsor: Bristol-Myers Squibb
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-07-20
Start Date Type: ACTUAL
Primary Completion Date: 2022-01-03
Primary Completion Date Type: ACTUAL
Completion Date: 2022-01-03
Completion Date Type: ACTUAL
First Submit Date: 2021-06-30
First Submit QC Date: None
Study First Post Date: 2021-07-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-02-24
Last Update Post Date: 2022-03-11
Last Update Post Date Type: ACTUAL